Completed NA INTERVENTIONAL 2-arm
NCT06778330
The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary Hypertension
Sponsor: Fayoum University
Conditions
Heart Failure NYHA Class II
Interventions
Dapagliflozin (DAPA) Sildenafil
Updated 3 times since 2025 Last updated: Sep 2, 2025 Started: Jan 20, 2025 Primary completion: Aug 1, 2025 Completion: Aug 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Heart Failure NYHA Class II, this trial is completed. The trial is conducted by Fayoum University and has accumulated 3 data snapshots since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
3 versions recorded-
Oct 2025 — Present [monthly]
Completed NA
-
Sep 2025 — Oct 2025 [monthly]
Completed NA
Status: Recruiting → Completed
-
Feb 2025 — Sep 2025 [monthly]
Recruiting NA
First recorded
Jan 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Fayoum University
Data source: Fayoum University
For direct contact, visit the study record on ClinicalTrials.gov .